These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 28275033)

  • 1. Comorbidity Scores and Machine Learning Methods Can Improve Risk Assessment in Radical Cystectomy for Bladder Cancer.
    Wessels F; Bußoff I; Adam S; Kowalewski KF; Neuberger M; Nuhn P; Michel MS; Kriegmair MC
    Bladder Cancer; 2022; 8(2):155-163. PubMed ID: 38993365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity and the diagnosis of symptomatic-but-as-yet-undiagnosed cancer.
    Renzi C; Lyratzopoulos G
    Br J Gen Pract; 2020 Sep; 70(698):e598-e599. PubMed ID: 32855148
    [No Abstract]   [Full Text] [Related]  

  • 3. Sarcopenia is an independent predictor of survival in patients undergoing radical cystectomy for bladder cancer: a single-centre, retrospective study.
    Erdik A; Cimen HI; Atik YT; Gul D; Kose O; Halis F; Saglam HS; Ates OF
    Cent European J Urol; 2023; 76(2):81-89. PubMed ID: 37483860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Ability of Comorbidity Indices for Surgical Morbidity and Mortality: a Systematic Review and Meta-analysis.
    Clements NA; Gaskins JT; Martin RCG
    J Gastrointest Surg; 2023 Sep; 27(9):1971-1987. PubMed ID: 37430092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can pelvic diameter measurement have an effect on surgical outcomes in radical cystectomy?
    Erdik A; Cimen HI; Kose O; Ates OF; Taydas O; Gul D; Saglam HS
    BMC Urol; 2023 Jun; 23(1):105. PubMed ID: 37286956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators.
    Russell B; Häggström C; Holmberg L; Liedberg F; Gårdmark T; Bryan RT; Kumar P; Van Hemelrijck M
    BJUI Compass; 2021 May; 2(3):140-158. PubMed ID: 35475135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Delivery of Follow-Up Care After Radical Cystectomy for Bladder Cancer.
    Jensen BT; Lauridsen SV; Jensen JB
    Res Rep Urol; 2020; 12():471-486. PubMed ID: 33117747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlighting the road towards new disease-specific comorbidity indices.
    Dell'Oglio P; Mazzone E; Tian Z; Karakiewicz PI
    Transl Androl Urol; 2020 Jun; 9(3):1475-1478. PubMed ID: 32676433
    [No Abstract]   [Full Text] [Related]  

  • 9. Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle?
    Regmi SK; Konety BR
    Transl Androl Urol; 2019 Jul; 8(Suppl 3):S314-S317. PubMed ID: 31392156
    [No Abstract]   [Full Text] [Related]  

  • 10. Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients.
    Williams SB; Kamat AM; Chamie K; Froehner M; Wirth MP; Wiklund PN; Black PC; Steinberg GD; Boorjian SA; Daneshmand S; Goebell PJ; Pohar KS; Shariat SF; Thalmann GN
    Eur Urol Oncol; 2018 Jun; 1(2):91-100. PubMed ID: 30345422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer.
    Mayr R; Fritsche HM; Zeman F; Reiffen M; Siebertz L; Niessen C; Pycha A; van Rhijn BWG; Burger M; Gierth M
    World J Urol; 2018 Aug; 36(8):1201-1207. PubMed ID: 29520591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting one-year survival after radical cystectomy: A prospective study.
    Kwiatkowska M; Dybowski B; Kuczkiewicz-Siemion O; Osiecki R; Śmigielska K; Gonczar S; Poletajew S; Radziszewski P
    Cent European J Urol; 2017; 70(3):238-244. PubMed ID: 29104785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy.
    Dell'Oglio P; Tian Z; Leyh-Bannurah SR; Larcher A; Mazzone E; Moschini M; Trudeau V; Stabile A; Gallina A; Suardi N; Capitanio U; Mottrie A; Briganti A; Montorsi F; Rochefort CM; Karakiewicz PI
    Ann Surg Oncol; 2019 Jun; 26(6):1942-1949. PubMed ID: 30919224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary 90-day mortality rates after radical cystectomy in the elderly.
    Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI
    Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study.
    Abdollah F; Sun M; Schmitges J; Thuret R; Djahangirian O; Jeldres C; Tian Z; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Ann Surg Oncol; 2012 Jan; 19(1):309-17. PubMed ID: 21701925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database.
    Schiffmann J; Sun M; Gandaglia G; Tian Z; Popa I; Larcher A; Briganti A; McCORMACK M; Shariat SF; Montorsi F; Graefen M; Saad F; Karakiewicz PI
    Minerva Urol Nefrol; 2017 Apr; 69(2):173-180. PubMed ID: 27733752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population based assessment of perioperative mortality after cystectomy for bladder cancer.
    Isbarn H; Jeldres C; Zini L; Perrotte P; Baillargeon-Gagne S; Capitanio U; Shariat SF; Arjane P; Saad F; McCormack M; Valiquette L; Peloquin F; Duclos A; Montorsi F; Graefen M; Karakiewicz PI
    J Urol; 2009 Jul; 182(1):70-7. PubMed ID: 19447427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy.
    Dell'Oglio P; Tian Z; Leyh-Bannurah SR; Trudeau V; Larcher A; Moschini M; Di Trapani E; Capitanio U; Briganti A; Montorsi F; Saad F; Karakiewicz PI
    J Natl Compr Canc Netw; 2017 Mar; 15(3):327-333. PubMed ID: 28275033
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.